Table 3 Effect of RSVL treatment on the cellular uptake of DOX in MCF-7 cells
From: Modulation of doxorubicin cytotoxicity by resveratrol in a human breast cancer cell line
Treatment | DOX Concentration (μg/106 x cells) | ||
|---|---|---|---|
Alone | Simultaneously with RSVL | RSVL 24 h before | |
DOX (0.5 μg/ml) | 0.041 ± 0.008 | 0.062 a ± 0.011 | 0.023 ± 0.001 |
DOX (0.25 μg/ml) | 0.027 ± 0.004 | 0.031 ± 0.005 | 0.024 ± 0.001 |
DOX (0.125 μg/ml) | 0.022 ± 0.004 | 0.021 ± 0.004 | 0.013 ± 0.002 |